Aurinia Pharmaceuticals Inc (AUPH)

[Lunacy_John Galt]

I haven't been around much lately, and I apologize...this has been mostly a pretty good group over the last few years. So here's a healthy dose of my recent thoughts all in one post...

When retail investors decide to enter the world of early-stage biotech investing, they do so with the goals of landing one or more of those winners where massive gains are realized in a relatively short time period. Those gains are out there to be had, but they often don't come easy or just fall into your lap.

You typically have to work for it. You have to put in the research, you have to be able to stomach massive volatility, and potential huge paper losses to get to the endgame. There are often long time periods of silence from the management teams. This is all very normal for these types of tickers. All rules seem to go out the window around major catalysts.

You've heard it a thousand times, but don't be that cliche holder that lets their emotions over price action dictate their behavior, rather than rational thought prevailing.

It can be a long, tough, grueling road, until one day it's not. Have a great weekend everyone!

On a separate note, this stinks of ILJIN. Their tactics this summer with the proxy vote and public hissy fit were completely unwarranted imo...and the timing of it all was complete nonsense. I would love nothing more than ILJIN to exit, and AUPH release the next iteration of THE BEST LN DATA EVER SEEN!

Glickman wanted to RE-retire. He did his part...he turned this thing around and gave it purpose and direction.

There was never going to be a perfect time. People complain about leaving pre-data. With that same thought process, he then couldn’t leave after data but pre Adcom, or after adcom but pre-fda approval, or after fda approval but pre-commercialization, or after commercialization but pre-BO...It could potentially be years before his re-retirement would be acceptable by a lot of your expectations.

I see a lot of recurring concerns here, so I thought I’d share my 2 cents as a long time holder from pre Ph2B.